Jo Jean Riley
About Jo Jean Riley
Jo Jean Riley is a Clinical Oncology Specialist at Bristol-Myers Squibb in the Greater Detroit Area, with over 20 years of experience in the oncology field.
Title
Jo Jean Riley is a Clinical Oncology Specialist currently working at Bristol-Myers Squibb in the Greater Detroit Area. Jo Jean Riley has held this position for over a decade, starting in August 2012.
Career at Bristol-Myers Squibb
Jo Jean Riley has been with Bristol-Myers Squibb for more than ten years. In the role of Clinical Oncology Specialist, Jo Jean Riley operates in the Greater Detroit Area. Riley's tenure at Bristol-Myers Squibb began in August 2012, focusing on clinical oncology.
Previous Experience in Oncology
Before joining Bristol-Myers Squibb, Jo Jean Riley worked in various oncology-specific roles. Riley served as a Territory Business Manager - Oncology at inVentiv Health in 2012 for a brief period of three months. From 2010 to 2012, Riley was a Diagnostic Sales Consultant at Genoptix Medical Laboratory. Earlier, Riley was employed at sanofi-aventis as an Oncology Therapeutic Specialist for six years, from 2004 to 2010. Riley started breaking into the oncology field as a Senior Representative at Janssen, Pharmaceutical Companies of Johnson and Johnson, from 1999 to 2004.
Educational Background in Counseling and Marketing
Jo Jean Riley holds a Master's degree in Counseling from Oakland University, completed in 1998. Riley also earned a Bachelor of Business Administration (BBA) in Marketing from Walsh College in 1990. This diverse educational background supports Riley's extensive experience in the oncology industry.
Extensive Experience in the Pharmaceutical Industry
Jo Jean Riley's career spans over two decades in the pharmaceutical and oncology sectors. With roles ranging from Senior Representative at Janssen, Pharmaceutical Companies of Johnson and Johnson to Oncology Therapeutic Specialist at sanofi-aventis, Riley has accumulated significant expertise in oncology. This experience is further complemented by a decade-long tenure at Bristol-Myers Squibb.